Roivant Sciences (ROIV) Research & Development (2020 - 2026)
Roivant Sciences (ROIV) recorded Research & Development of $202.02 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 32.1% from $152.92 million a year earlier and up 1.5% from the prior quarter.
Roivant Sciences (ROIV) Research & Development (2020 - 2026) Analysis & Trends
On a TTM basis, Roivant Sciences' Research & Development came in at $730.91 million as of Jun 30, 2026, up 25.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $681.81 million, up 23.9% from FY2025.
- Annual Research & Development has a five-year compound annual growth rate of 23.6% (FY2021 to FY2026).
- Across earlier fiscal years, Research & Development came in at $550.41 million in FY2025 (+25.1%), $439.91 million in FY2024 (-3.1%), $454.06 million in FY2023 (-6.0%) and $483.04 million in FY2022 (+104.1%).
- The fiscal Q1 2027 figure is the highest quarterly Research & Development since fiscal Q3 2021.
- On a year-over-year basis, Research & Development has increased for eight consecutive quarters, with growth averaging 27.3% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 77.2% in fiscal Q4 2024, against a decline of 55.1% in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $198.95 million (Q4 2026), $165.38 million (Q3 2026) and $164.57 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | 202.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 202.02 Mn |
| Mar 31, 2026 | 198.95 Mn |
| Dec 31, 2025 | 165.38 Mn |
| Sep 30, 2025 | 164.57 Mn |
| Jun 30, 2025 | 152.92 Mn |
| Mar 31, 2025 | 145.24 Mn |
| Dec 31, 2024 | 141.60 Mn |
| Sep 30, 2024 | 143.07 Mn |
| Jun 30, 2024 | 120.51 Mn |
| Mar 31, 2024 | 107.56 Mn |
| Dec 31, 2023 | 108.15 Mn |
| Sep 30, 2023 | 114.79 Mn |
| Jun 30, 2023 | 125.13 Mn |
| Mar 31, 2023 | 60.70 Mn |
| Dec 31, 2022 | 125.53 Mn |
| Sep 30, 2022 | 132.00 Mn |
| Jun 30, 2022 | 135.83 Mn |
| Mar 31, 2022 | 135.08 Mn |
| Dec 31, 2021 | 137.35 Mn |
| Sep 30, 2021 | 132.10 Mn |
Roivant Sciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();